Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$148,000.00
Dec 1, 2020
For-profit organization
Open Banking API integration
967835
EUREKA E! 13575 NEXBEST project with Nexi Payments SpA (Italy)
to develop an integration between the firm's Artificial Intelligence product with Nexi's open banking products in support of the partnership agreement co-sell the integrated solution to European banks, wealth manager and insurance companies.
$531,542.00
Dec 1, 2020
Not-for-profit organization or charity
Strategic Intervention - Workshop and Mentoring
968005
Intensive training and executive coaching program addressing key business issues necessary for SME innovation and growth.
$35,800.00
Dec 1, 2020
Not-for-profit organization or charity
Interactive visits and strategic intervention with innovative SMEs
968168
Program of interactive visits and strategic interventions with innovative SMEs.
$172,340.00
Dec 1, 2020
Not-for-profit organization or charity
Regulatory Affairs Support Services for Canadian SMEs 2 - (interactive tours)
968329
Personalized intervention of SMEs by experts of the organization in order to accompany them and to evaluate the progress on regulatory aspects.
$1,254,375.00
Dec 1, 2020
Academia
Infrastructure for electrochemical materials acceleration platforms
963521
The Electrochemical Material Acceleration Platforms (MAPs) Project will build an infrastructure to support the accelerated discovery and characterization of new materials in the area of electrocatalysis. Specifically, MAPs couples three leading edge technologies (artificial intelligence (AI), smart robotics, and high performance computing). During the Project, two MAPs will be developed. One will be used for sol-gel synthesis and the other for organic electrochemistry. Each will allow rapid characterization using both physical and electrochemical methods. Each of the MAPs will facilitate high-throughput experimentation that will lead to accelerated materials discovery of catalysts that can be used in technologies developed to produce clean fuels and reduce GHG emissions. The MAPs infrastructure will become part of a network of diverse MAPs, each being developed for different purposes but intended to be complimentary and used for collaborative research and discovery of materials.
$303,189.00
Dec 1, 2020
Individual or sole proprietorship
Operating Grant: Joint Programme on Neurodegenerative Disease Research (JPND)
158036
The specific objective of this funding opportunity is:
•to establish a number of ambitious, innovative, multi-disciplinary and multi-national collaborative research projects that will further advance the respective research areas.
$326,847.00
Dec 1, 2020
Individual or sole proprietorship
Operating Grant: Joint Programme on Neurodegenerative Disease Research (JPND)
158037
The specific objective of this funding opportunity is:
•to establish a number of ambitious, innovative, multi-disciplinary and multi-national collaborative research projects that will further advance the respective research areas.
$281,970.00
Dec 1, 2020
Individual or sole proprietorship
Operating Grant: Joint Programme on Neurodegenerative Disease Research (JPND)
158038
The specific objective of this funding opportunity is:
•to establish a number of ambitious, innovative, multi-disciplinary and multi-national collaborative research projects that will further advance the respective research areas.
$6,000,000.00
Dec 1, 2020
Individual or sole proprietorship
Op Gr: Network of Clinical Trials Networks: COVID-19 and Intervention Strategies
158424
Applications must ensure relevance to all of the following objectives:
• Establish central coordination and collaboration activities with existing clinical trials groups/networks to increase the availability of high-quality and real-time evidence and build capacity to support Canada’s rapid response to the global pandemic and health emergencies in order to better prevent, detect, treat and/or manage COVID-19;
• Establish a transparent, inclusive, multi-jurisdictional recruitment and membership process that describes benefits for and requirements and expectations of members;
• Collaborate across member networks to establish resource and data sharing policies, increase efficiencies in research and related processes (including, but not limited to ethics review; contracts; common protocols; developing applications for trial funding; consistent and valid patient-oriented outcomes), reduce duplication, and maximize research impact for COVID-19;
• Create data sharing agreements to ensure follow-up of patients through existing administrative data platforms within Canada;
• Adopt a nimble and adaptive strategy for engaging stakeholders in research prioritization and oversight while shifting studies as needed, based on new knowledge and changing COVID-19 landscape;
• Provide evidence to inform clinical and health system management and public health response, and/or decision-making and planning within and across jurisdictions in Canada and internationally; and
• Enhance local, national and/or international clinical trial collaborative efforts by aligning clinical trials networks with other COVID-19 research investments to prevent and/or mitigate the rapid spread of COVID-19 and related negative consequences.
$1,199,987.00
Dec 1, 2020
Individual or sole proprietorship
Operating Grant: CLSA COVID-19 Module
158379
The specific objectives of this directed grant are to support the:
• Collection of data from CLSA participants;
• Revision of the COVID-19 questionnaire as the pandemic evolves in the coming months;
• Generation of an electronic dataset that will be made available on the CLSA platform